Ticker Details
Tevogen Bio Holdings Inc. Common Stock
IPO Date:	February 15, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$24.4M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 5.62%
Avg Daily Range (30 D):	$0.25 | 4.91%
Avg Daily Range (90 D):	$0.11 | 4.76%

Institutional Daily Volume
Avg Daily Volume:	2.3M
Avg Daily Volume (30 D):	.25M
Avg Daily Volume (90 D):	.54M

Trade Size
Avg Trade Size (Sh.):	313
Avg Trade Size (Sh.) (30 D):	316
Avg Trade Size (Sh.) (90 D):	371

Institutional Trades
Total Institutional Trades:	4
Avg Institutional Trade:	$.83M
Avg Institutional Trade (30 D):	$.98M
Avg Institutional Trade (90 D):	$.98M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.86M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	18.27K

News

Mar 13, 2026 @ 6:45 PM Tevogen Reaffirms Capital Discipline as Lead Inves... Source: Na

Mar 11, 2026 @ 7:15 PM Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Comm... Source: Na

Mar 6, 2026 @ 5:42 PM Tevogen Bio Explores Buyout To Boost Generics Plat... Source: Vandana Singh

Mar 5, 2026 @ 7:50 PM Tevogen Advances Generics Strategy, Signs Letter o... Source: Globe Newswire

Mar 5, 2026 @ 7:50 PM Tevogen Advances Generics Strategy, Signs Letter o... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-8.08	$-7.96	$-8.08
Diluted EPS	$-8.08	$-7.96	$-8.08
Revenue	$-.2M	$-.07M	$-.2M
Gross Profit
Net Income / Loss	$-26.28M	$-4.68M	$-26.28M
Operating Income / Loss	$-26.14M	$-4.61M	$-26.14M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Mar 06, 2026	1:50